post-bg-559
calendary April 13, 2023

Termination of supplies of the drug "Ozempic" in the Russian Federation

In November 2022, Roszdravnadzor received a notification from the Novo Nordisk manufacturing company about the planned termination of supplies of the Ozempic drug to the Russian Federation.

It should be noted that according to the current legislation of the Russian Federation, the holder of the registration certificate must notify Roszdravnadzor in advance (1 year in advance) of the termination of the supply of the medicinal product. In November 2022, Novo Nordisk announced to RZN that it plans to supply Ozempic until December 2023. In general, the company did not announce about its exit from the Russian market.

Ozempic (active ingredient - semaglutide) is a hypoglycemic drug that is indicated for use in adult patients with type 2 diabetes on the background of diet and exercise to improve glycemic control and can be used as monotherapy or in combination with other hypoglycemic drugs.

It should be noted that according to the state register, semaglutide preparations are represented on the market only by the trade names Ozempic and Rebelsas. Both drugs are manufactured by Novo Nordisk.

Since 2022, Ozempic has been included in the list of vital and essential drugs (VED) - a list of drugs approved by the Government of the Russian Federation for the purpose of state regulation of prices for medicines. The maximum selling price for the drug Semaglutide, according to the state register, is 5.8 thousand rubles, and the maximum retail price should not exceed 7.7 thousand rubles, including VAT.

However, in November 2022, in the news columns of many online resources, at least two times the maximum registered price of Ozempic was noted in some pharmacies. According to RBC, the drug semaglutide was available in “Europharm” and “LekarPharma” for 16 thousand rubles.

At the same time, pharmacies offered in the application of the federal system of mandatory labeling "Chestniy Znack" (in the chains "Stolichki", "Neo-Pharm" and "Pharmacy A.v.e") do not have this drug.

References:
  1. https://tass.ru/obschestvo/17368215
  2. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=55719401-39c2-401b-ade5-5622d7b053c3
  3. https://grls.rosminzdrav.ru/PriceLims.aspx
  4. https://www.rbc.ru/newspaper/2022/11/16/637228a29a7947738ee1838d

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE